ST
Swing Therapeutics, Inc.
SEC filingOther Health Care · San Francisco, CA
Amount raised$3.3Msold at filing
Total offering$3.3M
Investors in the raise1count reported to the SEC
FiledSep 15, 2025first sale Aug 5, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael RosenbluthExecutive Officer, Director
Corey McCannDirector
Andrew FirlikDirector
Zack LynchDirector
Executive officers, directors and promoters as listed on the Form D.